Literature DB >> 2732026

Anterior chamber-associated immune deviation induced by soluble antigens.

K Mizuno1, A F Clark, J W Streilein.   

Abstract

Immune responses to cellular antigens placed in the anterior chamber of the eye are deviant: antibodies and cytotoxic T cells are generated, but delayed hypersensitivity is impaired. To determine whether a similar pattern of unusual reactivity would be induced by soluble antigens placed in this privileged site, we have examined the systemic immune responses of mice to anterior chamber injections of bovine serum albumin and bovine retinal S antigen--both soluble molecules. Recipients of intraocular injections of these antigens without adjuvant developed no detectable systemic immune response. When BSA was mixed with complete or incomplete Freund's adjuvant and injected into the anterior chamber, recipients produced serum specific antibodies; however, they displayed impaired delayed hypersensitivity. Anterior chamber recipients of soluble antigens subsequently proved refractory to the development of delayed hypersensitivity when immunogenic doses of the same antigens were placed subcutaneously. Moreover, the inability to mount delayed hypersensitivity could be adoptively transferred with spleen cells from animals that had previously received intraocular injections of bovine albumin or S antigen. It is concluded that soluble antigens, as well as surface membrane-bound antigens, are capable of inducing anterior chamber-associated immune deviation (ACAID). The possibility is discussed that the capacity of soluble retinal S antigen to induce ACAID may be pertinent to the maintenance of self-tolerance to this autologous, intraocular molecule.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2732026

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  Characterization of suppressor cells in anterior chamber-associated immune deviation (ACAID) induced by soluble antigen. Evidence of two functionally and phenotypically distinct T-suppressor cell populations.

Authors:  G A Wilbanks; J W Streilein
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

2.  gammadelta T cells are critical for the induction of anterior chamber-associated immune deviation.

Authors:  Y Xu; J A Kapp
Journal:  Immunology       Date:  2001-10       Impact factor: 7.397

3.  Requirement for splenic CD4+ T cells in the immune privilege of the anterior chamber of the eye.

Authors:  M Takahashi; N Ishimaru; K Yanagi; K Saegusa; N Haneji; H Shiota; Y Hayashi
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

4.  Distinctive humoral immune responses following anterior chamber and intravenous administration of soluble antigen. Evidence for active suppression of IgG2-secreting B lymphocytes.

Authors:  G A Wilbanks; J W Streilein
Journal:  Immunology       Date:  1990-12       Impact factor: 7.397

5.  Incomplete activation of lymphokine-producing T cells by alloantigenic intraocular tumours in anterior chamber-associated immune deviation.

Authors:  Y Bando; B R Ksander; J W Streilein
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

6.  Regulation of interphotoreceptor retinoid-binding protein (IRBP)-specific Th1 and Th17 cells in anterior chamber-associated immune deviation (ACAID).

Authors:  Yan Cui; Hui Shao; Deming Sun; Henry J Kaplan
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05-20       Impact factor: 4.799

Review 7.  Ocular immune privilege and CTL tolerance.

Authors:  Kyle C McKenna; Judith A Kapp
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.